Chemosensitivity and Endocrine Sensitivity Predicted by MammaPrint and BluePrint in the Prospective Neoadjuvant Breast Registry Symphony Trial
Published In/Presented At
Gittleman, M. (2013, December 10-14). Chemosensitivity and endocrine sensitivity predicted by mammprint and blueprint in the prospective neoadjuvant breast registry symphony trial. Poster presented at: The San Antonio Breast Cancer Symposium, San Antonio, TX.
Medical Specialties | Medicine and Health Sciences | Other Medical Specialties | Surgery
Department of Surgery
This document is currently not available here.